OR – Pharmacy Orders
ALL ORDERS MUST HAVE DATE, TIME WRITTEN, WRITER'S AND TRANSCRIBER'S LEGIBLE SIGNATURE (FIRST INITIAL, LAST NAME, TITLE) AND TRANSCRIPTION TIME. DIAGNOSIS AND ALLERGIES TO BE INCLUDED IN ALL ADMIT ORDERS. Attending: Diagnosis: Allergies: (List or note NKA)
Authorization is hereby given to dispense the generic or chemical equivalent unless otherwise indicated by the words “No Substitute.”
Orders – Signatures – Transcription Times
Anesthesia – Continuous Infusions (Note: Appropriate weight based standard concentration drips will be dispensed) អ Alprostadil
Baclofen (Please order in the specified increments)អ Test Dose 50 mcg/ml 1 mlអ Concentration 500 mcg/ml Volume needed:__________ ml (20 ml increments)អ Concentration 2000 mcg/ml
Volume needed:__________ ml (10 ml increments)
Caffeine Citrate Dose (based on citrate)អ 20 - 40 mg/kg = _____________ mg IV x 1 (500 mg max dose as citrate)Cidofovir (in Normal Saline)Concentration:
អ 5 mg/ml OR
អ 7.5 mg/ml OR អ 10 mg/ml
Cocaine Topical Solutionអ 4% topical solution 4 ml vialEye Meds (check meds needed): អ Fortified Tobramycin អ Fortified Vancomycin
អ Subconjunctival Gentamicin 40 mg/ml x 1 ml
Mitomycin អ 0.3 mg/ml Volume Needed: ______________ ml អ 0.4 mg/ml Volume Needed: ______________ ml អ 1 mg/ml Volume Needed: ______________ ml Pneumococcal Vaccine (must have consent) អ Prevnar 0.5 ml IM x 1 (use for patients less than 2 years old) អ Pneumovax 0.5 ml IM x 1 (use for patients 2 years old or greater) Ampicillin/Sulbactam (Unasyn) (Standardized Dosing)
Vancomycin/Gentamicin for Shunt Procedures (Preservative Free) អ Vancomycin 5 mg/ml in NS 2 ml អ Gentamicin 2 mg/ml in NS 0.23 ml Other Orders: PLEASE SEND ALL MEDICATIONS TO OR ROOM # _____________ DO NOT WRITE IN BARCODE AREA OR – Pharmacy Orders
ALL ORDERS MUST HAVE DATE, TIME WRITTEN, WRITER'S AND TRANSCRIBER'S LEGIBLE SIGNATURE (FIRST INITIAL, LAST NAME, TITLE) AND TRANSCRIPTION TIME. DIAGNOSIS AND ALLERGIES TO BE INCLUDED IN ALL ADMIT ORDERS. Attending: Diagnosis: Allergies: (List or note NKA)
Authorization is hereby given to dispense the generic or chemical equivalent unless otherwise indicated by the words “No Substitute.”
Orders – Signatures – Transcription Times
Anesthesia – Continuous Infusions (Note: Appropriate weight based standard concentration drips will be dispensed) អ Alprostadil
Baclofen (Please order in the specified increments)អ Test Dose 50 mcg/ml 1 mlអ Concentration 500 mcg/ml Volume needed:__________ ml (20 ml increments)អ Concentration 2000 mcg/ml
Volume needed:__________ ml (10 ml increments)
Caffeine Citrate Dose (based on citrate)អ 20 - 40 mg/kg = _____________ mg IV x 1 (500 mg max dose as citrate)Cidofovir (in Normal Saline)Concentration:
អ 5 mg/ml OR
អ 7.5 mg/ml OR អ 10 mg/ml
Cocaine Topical Solutionអ 4% topical solution 4 ml vialEye Meds (check meds needed): អ Fortified Tobramycin អ Fortified Vancomycin
អ Subconjunctival Gentamicin 40 mg/ml x 1 ml
Mitomycin អ 0.3 mg/ml Volume Needed: ______________ ml អ 0.4 mg/ml Volume Needed: ______________ ml អ 1 mg/ml Volume Needed: ______________ ml Pneumococcal Vaccine (must have consent) អ Prevnar 0.5 ml IM x 1 (use for patients less than 2 years old) អ Pneumovax 0.5 ml IM x 1 (use for patients 2 years old or greater) Ampicillin/Sulbactam (Unasyn) (Standardized Dosing)
Vancomycin/Gentamicin for Shunt Procedures (Preservative Free) អ Vancomycin 5 mg/ml in NS 2 ml អ Gentamicin 2 mg/ml in NS 0.23 ml Other Orders: PLEASE SEND ALL MEDICATIONS TO OR ROOM # _____________ DO NOT WRITE IN BARCODE AREA
Brief Report Right Prefrontal Repetitive Transcranial Magnetic Stimulation in Obsessive-Compulsive Disorder: A Double-Blind, Placebo-Controlled Study Pino Alonso, M.D. Method: Patients were randomly assigned to 18 sessions of Jesús Pujol, M.D., Ph.D. real (N=10) or sham (N=8) rTMS. Treatments lasted 20 minutes,and the frequency was 1 Hz for both conditions, but the inten- Na
T i m b e r & W o o d P r o d u c t s : P r e s e r v a t i v e s , B i n d e r s , F i x i n g Preservatives in Timber Products W hil e a com prehensi ve revi ew i s beyond the scope of thi s docum ent, a wi de range of treatm ents i s avai l abl e, with varyi ng l evel s of human and envi ronm ental toxi city. Very toxi c chemi cal s have histori call y been i ntroduced i nto our ho